GAI
CYTK icon

General American Investors’s Cytokinetics CYTK Stock Holding History

General American Investors’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-131,535
Closed -$855K – 59
2013
Q4 		$855K Hold
131,535
– – 0.07% 58
2013
Q3 		$996K Sell
131,535
-3
-0% -$32 0.09% 56
2013
Q2 		$1.52M Buy
+131,538
New +$1.04M 0.14% 57

Other funds holding CYTK

LPLP
Lansdowne Partners Limited Partnership London, United Kingdom $11.9B AUM 36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
SCA
SAC Capital Advisors Stamford, Connecticut $19.3B AUM 31.93% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BCPEM
Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

General American Investors's CYTK Position: Q1 2014 in Review

General American Investors sold out of Cytokinetics (CYTK) in Q1 2014, closing a stake of 131,535 shares — an estimated $855K sold.

General American Investors first reported a position in CYTK in Q2 2013 and held it in 3 quarters. The position peaked at $1.52M in Q2 2013. 109 funds tracked by Wall St. Rank hold CYTK as of Q1 2014.

  • General American Investors reported no remaining Cytokinetics position as of Q1 2014 after selling out during the quarter.
  • General American Investors sold 131,535 Cytokinetics shares in Q1 2014, an estimated $855K.
  • General American Investors first reported a position in Cytokinetics in Q2 2013 and held it in 3 quarters.
  • General American Investors's Cytokinetics position peaked at $1.52M in Q2 2013.
  • 109 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2014.

Based on General American Investors's 13F filing for Q1 2014, filed 1 May 2014.